Award of CE Mark Certificate
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, is pleased to announce the award of the CE mark certificate for CSD500, the Company's novel condom.
CSD500 is clinically proven to produce a firmer erection and increase penile size in healthy men whilst wearing a condom during sexual intercourse and to give women a longer lasting sexual experience.
The award of the CE mark means that CSD500 can be marketed in all European territories and also in a number of non-European territories that recognise the CE mark process.
Steven Cugine, Church & Dwight's President of International Consumer Products, commented: "We congratulate Futura on gaining regulatory approval in Europe for CSD500 and we look forward to continuing to work with Futura towards the launch of this extremely novel condom."
James Barder, Futura's Chief Executive, commented: "We are delighted to receive the CE mark certificate for CSD500. This means that the product is now approved for marketing throughout Europe, where it has already been licensed to Church & Dwight, owner of the highly trusted Trojan brand, in certain key territories. Discussions are proceeding well with potential licensing partners for other territories within Europe, and also for other territories worldwide."
For further information please contact:
Cenkos Securities plc
Tel:+44 (0)20 7397 8900
For media enquiries please contact:
Buchanan Communications Limited
Mark Court / Fiona Henson /
Tel: +44 (0) 20 7466 5000
Posted: October 2013